R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

The popular harem action series High School DxD is getting a new spinoff manga series based on the descendant of Miyamoto ...

FDA designates T-DXd plus pertuzumab as breakthrough therapy for HER2-positive metastatic breast cancer, promising improved survival rates for patients. The FDA has granted breakthrough therapy ...

The rate of intracranial response was 23.8% in the breast cancer cohort. Patritumab deruxtecan (HER3-DXd) demonstrated activity in a phase 2 trial of patients with advanced cancers who had brain ...

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...

High School DxD Producer: “It’s kind of a necessity” We Sell Our Uncensored Content on Blu-Ray Because We Can’t Legally Air it on TV High School DxD producer cleverly included uncensored content ...

Ali is blessed with the opportunity to use his love of gaming and anime, along with his writing skills, to create intriguing and educational content for a wide range of topics as a passionate and ...

New analysis of the DESTINY-Breast06 trial demonstrated that trastuzumab deruxtecan (T-DXd) provides meaningful clinical benefit regardless of time to progression on prior endocrine therapy, offering ...

“It was a hard decision”: Actual Reason High School DxD Had to Change its Character Designs Wasn’t the Female Objectification Backlash High School DxD's character design changes weren't due to ...

Adrian is a writer with a passion for everything Game Rant specializes in: anime, video games, and movies. He's produced content about these topics on several other sites for years now, and Game Rant ...